AI

Biotech AI Rises: Converge Bio Nabs $25M Backing from Tech Giants' Leaders!

Converge Bio, a leading startup in AI-driven drug discovery, has secured $25 million in Series A funding to accelerate its mission of transforming pharmaceutical R&D. The company leverages generative AI, trained on molecular data, to create integrated systems for antibody design, protein optimization, and biomarker discovery, significantly reducing drug development timelines. This investment under...

AI Unicorn Alert: Deepgram Secures $130M, Buys Startup, Hits $1.3B Valuation!

Deepgram, a leading voice AI model provider, has secured $130 million in Series C funding, led by AVP, achieving a $1.3 ...

By Uche Emeka

Apple's Shocking AI Play: Why Cupertino Snubbed OpenAI for Google's Gemini

Apple's multi-year agreement to integrate Google's Gemini models into its revamped Siri signifies a major shift in its A...

By Uche Emeka

Microsoft's Brad Smith Demands Big Tech Shoulder AI Data Center Costs Amid Fierce Opposition

AI data center expansion faces significant public backlash over strained electricity grids and water resources. Microsof...

By Uche Emeka